LTZ Therapeutics
PrivateLast Round
Early Funding
May 6, 2026
Total Funding Raised
$125M
Momentum Score
25 /100
Company Overview
LTZ Therapeutics is a biotechnology company focused on developing innovative immunotherapies aimed at treating cancer and other diseases through the integration of reverse translational science, tumor biology, and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LTZ Therapeutics Comps
Public and private peers based on sector, stage, and business model.
LTZ Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 6, 2026 | ||||
| Series A Extension | Apr 25, 2025 | ||||
| Series A | Jul 30, 2024 | ||||
| Early Funding | May 31, 2023 | ||||
| Seed | Apr 7, 2022 |
Key People
Founding team and executive leadership
LTZ Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lanchi Ventures | Early Funding, Series A Extension |
| Boyu Capital | Early Funding, Series A Extension |
| Zoo Capital | Series A Extension |
| Hillhouse Investment | Series A |
| Lapam Capital | Series A Extension, Series A |
| GL Ventures | Series A, Series A Extension, Early Funding |
| Unicorn Capital Partners | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2026
Raised $38M led by GL Ventures
- Nov 26, 2025
Developing myeloid cell engagers for therapeutic use.
LTZ Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LTZ Therapeutics's valuation, stock price, and market status.
